Plozasiran
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Lessons from recent clinical trials for the prevention of acute pancreatitis in chylomicronemia syndromes.
Journal: Current opinion in endocrinology, diabetes, and obesity
Published: November 10, 2025
The Efficacy and Safety of Plozasiran on Lipid Profile in Dyslipidemic Disorders: A Systematic Review and Meta-Analysis.
Journal: Cardiovascular drugs and therapy
Published: October 10, 2025
Approach to the Adult Patient with Chylomicronemia.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 01, 2025
An Updated Review of Novel Triglyceride-Lowering Therapies in Adults with Familial Chylomicronemia Syndrome.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: August 20, 2025
Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease.
Journal: Current atherosclerosis reports
Published: July 17, 2025
Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide.
Journal: American journal of preventive cardiology
Published: July 02, 2025
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?
Journal: Current atherosclerosis reports
Published: June 28, 2025
Targeting Triglycerides: The Rise of Apolipoprotein C3 and Angiopoietin-Like Protein 3 Inhibitors.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions
Published: June 23, 2025
Discovery of long-acting APOC3 siRNA for treating patients with hypertriglyceridemia.
Journal: Nucleic acids research
Published: June 16, 2025
Course of Pregnancy in a Woman With Familial Chylomicronemia Syndrome Treated With Plozasiran, a Small Interfering RNA Against ApoC3.
Journal: JIMD reports
Published: June 06, 2025
Population Pharmacokinetic Modeling of Subcutaneous Plozasiran in Healthy Volunteers and Patients with Familial Chylomicronemia Syndrome, Severe Hypertriglyceridemia, and Mixed Hyperlipidemia.
Journal: Journal of clinical pharmacology
Published: April 23, 2025
Last Updated: 02/24/2026